Patient-Reported Outcomes in NRG Oncology/RTOG 0938, a Randomized Phase 2 Study Evaluating 2 Ultrahypofractionated Regimens (UHRs) for Prostate Cancer

被引：14

作者：

Lukka, H. ^{[1
]}

Stephanie, P. ^{[2
]}

Bruner, D. ^{[3
]}

Bahary, J. P. ^{[4
]}

Lawton, C. A. F. ^{[5
]}

Efstathiou, J. A. ^{[6
]}

Kudchadker, R. ^{[7
]}

Ponsky, L. ^{[8
]}

Seaward, S. A. ^{[9
]}

Dayes, I. S. ^{[10
]}

Gopaul, D. D. ^{[11
]}

Michalski, J. M. ^{[12
]}

Delouya, G. ^{[13
]}

Kaplan, I. D. ^{[14
]}

Horwitz, E. M. ^{[15
]}

Roach, M., III ^{[16
]}

Pinover, W. H. ^{[17
]}

Beyer, D. C. ^{[18
]}

Sandler, H. M. ^{[19
]}

Kachnic, L. A. ^{[20
]}

机构：

[1] Juravinski Canc Ctr Hamilton Hlth Sci, Hamilton, ON, Canada

[2] NRG Oncol Stat & Data Management Ctr, Philadelphia, PA USA

[3] Emory Univ, Atlanta, GA 30322 USA

[4] Hop Notre Dame CHUM, Montreal, PQ, Canada

[5] Med Coll Wisconsin, Milwaukee, WI 53226 USA

[6] Harvard Univ, Sch Med, Massachusetts Gen Hosp, Boston, MA 02115 USA

[7] Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USA

[8] Univ Hosp Seidman Canc Ctr, Case Comprehens Canc Ctr, Cleveland, OH USA

[9] Kaiser Permanente No Calif, Santa Clara, CA USA

[10] McMaster Univ, Hamilton, ON, Canada

[11] Grand River Reg Canc Ctr, Kitchener, ON, Canada

[12] Washington Univ, Sch Med, St Louis, MO USA

[13] Ctr Hosp Univ Montreal, Montreal, PQ, Canada

[14] Beth Israel Deaconess Med Ctr, Boston, MA 02215 USA

[15] Fox Chase Canc Ctr, Philadelphia, PA 19111 USA

[16] Univ Calif San Francisco, San Francisco, CA 94143 USA

[17] Abington Mem Hosp, Abington, PA 19001 USA

[18] Fdn Canc Res & Educ, Phoenix, AZ USA

[19] Cedars Sinai Med Ctr, Los Angeles, CA 90048 USA

[20] Boston Med Ctr, Boston, MA USA

来源：

INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS | 2016年 / 94卷 / 01期

关键词：

D O I：

10.1016/j.ijrobp.2015.10.046

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

LBA 3

引用

页码：2 / 2

页数：1

共 50 条

[11] NRG Oncology/RTOG 0415, hypofractionation in patients with low-risk prostate cancer: are patient reported outcomes the practice change tipping point?
Pugh, Stephanie L.
Lee, W. R.
Dignam, James
Low, Daniel
Swanson, Gregory P.
Shah, Amit B.
D'Souza, David P.
Michalski, Jeff M.
Dayes, Ian S.
Seaward, Samantha A.
Nguyen, Paul L.
Hall, William A.
Pisansky, Thomas M.
Chen, Yuhchyau
Sandler, Howard M.
Movsas, Benjamin
Bruner, Deborah W.
QUALITY OF LIFE RESEARCH, 2017, 26 (01) : 38 - 39
[12] Patient-Reported Outcomes in the Acute Phase of the Randomized Hypofractionated Irradiation for Prostate Cancer (HYPRO) Trial
Sinzabakira, Felix
Heemsbergen, Wilma D.
Pos, Floris J.
Incrocci, Luca
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2022, 112 (04): : 870 - 879
[13] Improvement in Patient-Reported Outcomes With Intensity-Modulated Radiotherapy (RT) Compared With Standard RT: A Report From the NRG Oncology RTOG 1203 Study
Yeung, Anamaria R.
Pugh, Stephanie L.
Klopp, Ann H.
Gil, Karen M.
Wenzel, Lari
Westin, Shannon N.
Gaffney, David K.
Small, William, Jr.
Thompson, Spencer
Doncals, Desiree E.
Cantuaria, Guilherme H. C.
Yaremko, Brian P.
Chang, Amy
Kundapur, Vijayananda
Mohan, Dasarahally S.
Haas, Michael L.
Kim, Yong
Ferguson, Catherine L.
Deshmukh, Snehal
Bruner, Deborah W.
Kachnic, Lisa A.
JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (15) : 1685 - +
[14] Patient-reported outcomes at discontinuation of anti-angiogenesis therapy in the randomized trial of chemotherapy with bevacizumab for advanced cervical cancer: an NRG Oncology Group study
Chase, Dana
Huang, Helen Q.
Monk, Bradley J.
Ramondetta, Lois Michelle
Penson, Richard T.
Gil, Karen
Landrum, Lisa M.
Leitao, Mario
Oaknin, Ana
Huh, Warner K.
Pulaski, Heather L.
Robison, Katina
Guntupalli, Saketh R.
Richardson, Debra
Salani, Ritu
Sill, Michael W.
Wenzel, Lari B.
Tewari, Krishnansu Sujata
INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2020, 30 (05) : 596 - 601
[15] Bevacizumab for advanced cervical cancer: patient-reported outcomes of a randomised, phase 3 trial (NRG Oncology-Gynecologic Oncology Group protocol 240)
Penson, Richard T.
Huang, Helen Q.
Wenzel, Lari B.
Monk, Bradley J.
Stockman, Sharon
Long, Harry J., III
Ramondetta, Lois M.
Landrum, Lisa M.
Oaknin, Ana
Reid, Thomas J. A.
Leitao, Mario M.
Method, Michael
Michael, Helen
Tewari, Krishnansu S.
LANCET ONCOLOGY, 2015, 16 (03): : 301 - 311
[16] Patient Reported Outcomes of NRG Oncology/RTOG 0232: A Phase III Study Comparing Combined External Beam Radiation and Transperineal Interstitial Permanent Brachytherapy with
Moughan, J.
Prestidge, B. R.
Sanda, M. G.
Bice, W.
Michalski, J. M.
Ibbott, G. S.
Amin, M.
Catton, C. N.
Donavanik, V.
Gay, H. A.
Brachman, D. G.
Frank, S. J.
Rosenthal, S. A.
Matulonis, U.
Sadeghi, A.
Winter, K.
Sandler, H. M.
Papagikos, M. A.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2018, 102 (03): : S2 - S3
[17] Toxicity and Patient-Reported Outcomes of a Phase 2 Randomized Trial of Prostate and Pelvic Lymph Node Versus Prostate only Radiotherapy in Advanced Localised Prostate Cancer (PIVOTAL)
Dearnaley, David
Griffin, Clare L.
Lewis, Rebecca
Mayles, Philip
Mayles, Helen
Naismith, Olivia F.
Harris, Victoria
Scrase, Christopher D.
Staffurth, John
Syndikus, Isabel
Zarkar, Anjali
Ford, Daniel R.
Rimmer, Yvonne L.
Horan, Gail
Khoo, Vincent
Frew, John
Venkitaraman, Ramachandran
Hall, Emma
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2019, 103 (03): : 605 - 617
[18] Patient-Reported Outcomes in a Randomized Trial of Bevacizumab in the Treatment of Advanced Cervical Cancer: a Gynecologic Oncology Group Study
Penson, Richard T.
Huang, Helen Q.
Wenzel, Lari
Tewari, Krishnansu
Monk, Bradley J.
Sill, Michael
Stockman, Sharon
Ramondetta, Lois
Landrum, Lisa
Oaknin, Ana
Reid, Thomas
Leitao, Mario
QUALITY OF LIFE RESEARCH, 2014, 23 : 68 - 68
[19] Patient Reported Outcomes and Early Toxicity from a Phase III Randomized Trial of Moderate vs. Ultrahypofractionated Radiation Therapy for Localized Prostate Cancer
Farnia, Benjamin
Dal Pra, Alan
Kwon, Deukwoo
Punnen, Sanoj
Ricardi, Umberto
Levis, Mario
Eade, Thomas
Dogan, Nesrin
Stoyanova, Radka
Abramowitz, Matthew
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2020, 108 (02): : E21 - E21
[20] Stereotactic ultrahypofractionated MR-guided radiotherapy for localized prostate cancer - Acute toxicity and patient-reported outcomes in the prospective, multicenter SMILE phase II trial
Fink, C. A.
Ristau, J.
Buchele, C.
Klueter, S.
Liermann, J.
Hoegen-Sassmannshausen, P.
Sandrini, E.
Lentz-Hommertgen, A.
Baumann, L.
Andratschke, N.
Baumgartl, M.
Li, M.
Reiner, M.
Corradini, S.
Hoerner-Rieber, J. Ho
Bonekamp, D.
Schlemmer, H. -P.
Belka, C.
Guckenberger, M.
Debus, J.
Koerber, S. A.
CLINICAL AND TRANSLATIONAL RADIATION ONCOLOGY, 2024, 46

← 1 2 3 4 5 →